oxazoles has been researched along with Cancer of Prostate in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Cowled, MS; Lacey, E; Lacey, H; Piggott, AM; Rutledge, PJ; Vuong, D | 1 |
| Lorenzetti, S; Mantovani, A; Marcoccia, D; Smeriglio, A; Trombetta, D | 1 |
| Latysheva, AS; Misharin, AY; Morozevich, GE; Novikov, RA; Scherbakov, KA; Veselovsky, AV; Zhdanov, DD; Zolottsev, VA | 1 |
| Gu, S; Peng, Y; Sang, H; Sun, J; Wang, G; Wang, Y; Zhong, Y | 1 |
| Ding, N; Kanada, Y; Kanazaki, K; Ono, M; Saji, H; Sano, K | 1 |
| Kostin, VA; Kuzikov, AV; Latysheva, AS; Misharin, AY; Morozevich, GE; Novikov, RA; Shumyantseva, VV; Timofeev, VP; Tkachev, YV; Zolottsev, VA | 1 |
| Dorr, RT; Landowski, TH; Samulitis, BK | 1 |
| Kotapalli, SS; Naresh, A; Ummanni, R; Venkateswara Rao, B; Venkateswara Rao, M | 1 |
| Fan, Y; Gao, C; Ge, Z; Gong, W; He, S; Huang, X; Shan, L; Tong, Y; Wang, Y; Yang, M | 1 |
| Ahmed Ali, AA; Chang, DM; Chang, WW; Chen, CL; Chen, TC; Guh, JH; Huang, HS; Lee, CC; Liu, FL | 1 |
| Rivest, P; Robitaille, CN; Sanderson, JT | 1 |
| Ikeda, D; Inoue, H; Kawada, M; Usami, I | 1 |
| Liu, XH; Lv, PC; Song, BA; Xue, JY; Zhu, HL | 1 |
| Al-Abed, Y; Basile, F; Biondi, A; Donia, M; Maksimovic-Ivanic, D; Mangano, K; Mijatovic, S; Miljkovic, D; Nicoletti, F; Stosic-Grujicic, S; Tumino, S | 1 |
| Adedeji, D; Bakare, O; Brandy, Y; Butcher, RJ; Copeland, RL; Denmeade, SR; Kanaan, Y; Mouamba, C; Ononiwu, I; Williams, V; Wright, DA | 1 |
| Harada, K; Kubo, H; Nishioka, K; Tanaka, A | 1 |
| Lehen'kyi, V; Mariot, P; Prevarskaya, N; Raphaël, M; Slomianny, C; Thébault, S; Vanden Abeele, F; Vanoverberghe, K | 1 |
| Kamoi, K; Kawauchi, A; Miki, T; Mizutani, Y; Ukimura, O | 1 |
| Dong, MS; Kim, HJ; Park, YI | 1 |
| Boon-Unge, K; Govitrapong, P; Yu, Q; Zhou, A; Zhou, J; Zou, T | 1 |
| Larrick, JW; Torti, FM; Wright, SC; Zheng, H; Zhong, J | 1 |
| Furudate, S; Nishimaki, T | 1 |
22 other study(ies) available for oxazoles and Cancer of Prostate
| Article | Year |
|---|---|
Yeppoonic acids A - D: 1,2,4-trisubstituted arene carboxylic acid co-metabolites of conglobatin from an Australian Streptomyces sp.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Australia; Carboxylic Acids; Cell Line, Tumor; Humans; Male; Mice; Multiple Myeloma; Oxazoles; Prostatic Neoplasms; Queensland; Soil Microbiology; Streptomyces | 2022 |
Intracellular distribution of vinclozolin and its metabolites differently affects 5α-dihydrotestosterone (DHT)-induced PSA secretion in LNCaP cells.
Topics: Androgen Antagonists; Androgens; Cell Line, Tumor; Dihydrotestosterone; Flutamide; Humans; Male; Oxazoles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen | 2022 |
Oxazolinyl derivatives of androst-16-ene as inhibitors of CYP17A1 activity and prostate carcinoma cells proliferation: Effects of substituents in oxazolinyl moiety.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Male; Oxazoles; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship | 2023 |
Quantitative determination of proxalutamide in rat plasma and tissues using liquid chromatography/tandem mass spectrometry.
Topics: Animal Structures; Animals; Biological Availability; Chromatography, High Pressure Liquid; Humans; Male; Oxazoles; Plasma; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Thiohydantoins; Tissue Distribution | 2021 |
Brachytherapy with Intratumoral Injections of Radiometal-Labeled Polymers That Thermoresponsively Self-Aggregate in Tumor Tissues.
Topics: Animals; Brachytherapy; Cell Line, Tumor; Indium Radioisotopes; Injections, Intralesional; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oxazoles; Polymerization; Prostatic Neoplasms; Radiopharmaceuticals; Temperature; Tissue Distribution; Yttrium Radioisotopes | 2017 |
Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth.
Topics: Antineoplastic Agents; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Electrochemistry; Humans; Male; Molecular Docking Simulation; Norpregnenes; Oxazoles; Prostatic Neoplasms; Protein Conformation; Steroid 17-alpha-Hydroxylase | 2018 |
The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers.
Topics: Animals; Antineoplastic Agents; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Hematologic Neoplasms; Humans; Male; Mice; Mice, SCID; Oxazoles; Prostatic Neoplasms; Pyridines; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2013 |
Oxazolidinone derivatives: cytoxazone-linezolid hybrids induces apoptosis and senescence in DU145 prostate cancer cells.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cellular Senescence; Humans; Linezolid; Male; Membrane Potential, Mitochondrial; Oxazoles; Oxazolidinones; Prostatic Neoplasms | 2014 |
Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Topics: Animals; Animals, Inbred Strains; Antineoplastic Agents; Biological Availability; Cinnamates; Citric Acid; Dogs; Drug Compounding; Drugs, Investigational; Excipients; Fumarates; Hydrogen-Ion Concentration; Imidazoles; Male; Nitriles; Oxazoles; Povidone; Prostatic Neoplasms; Random Allocation; Solubility; Succinic Acid; Suspensions; Tablets; Thiohydantoins | 2014 |
Ring fusion strategy for the synthesis of anthra[2,3-d]oxazole-2-thione-5,10-dione homologues as DNA topoisomerase inhibitors and as antitumor agents.
Topics: Anthraquinones; Antineoplastic Agents; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Oxazoles; Prostatic Neoplasms; Structure-Activity Relationship; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2014 |
Antiandrogenic mechanisms of pesticides in human LNCaP prostate and H295R adrenocortical carcinoma cells.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Androgen Antagonists; Antineoplastic Agents, Hormonal; Benomyl; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 Enzyme Inhibitors; Dihydrotestosterone; Dose-Response Relationship, Drug; Humans; Imidazoles; Kallikreins; Male; Membrane Proteins; Oxazoles; Pesticides; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Steroid 17-alpha-Hydroxylase | 2015 |
Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions.
Topics: Antineoplastic Agents; Cell Communication; Cell Line, Tumor; Fatty Alcohols; Humans; Insulin-Like Growth Factor I; Male; Oxazoles; Polyunsaturated Alkamides; Prostatic Neoplasms; Stromal Cells; Transforming Growth Factor beta1 | 2009 |
Novel 2,4,5-trisubstituted oxazole derivatives: synthesis and antiproliferative activity.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Oxazoles; Prostatic Neoplasms; Structure-Activity Relationship | 2009 |
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.
Topics: Acetates; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Concanavalin A; Female; Hepatitis, Autoimmune; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Nitric Oxide Donors; Oxazoles; Prostatic Neoplasms; Transplantation, Heterologous | 2009 |
Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.
Topics: Androgens; Benzoxazoles; Cell Death; Cell Line, Tumor; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Male; Naphthoquinones; Oxazoles; Prostatic Neoplasms | 2012 |
Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors.
Topics: 17-Hydroxysteroid Dehydrogenases; Carbon; Cell Nucleus; Chemistry, Pharmaceutical; Drug Design; Enzyme Inhibitors; Genes, Reporter; HeLa Cells; Humans; Inhibitory Concentration 50; Isoenzymes; Male; Models, Chemical; Models, Molecular; Molecular Conformation; Oxazoles; Prostate; Prostatic Neoplasms; Thiazolidinediones | 2012 |
Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells.
Topics: Actins; Androgens; Apoptosis; Calcium; Calcium Channels; Cell Differentiation; Cell Line, Tumor; Cytochalasin D; Cytoskeleton; DNA Primers; Electrophysiology; Humans; Male; Marine Toxins; Membrane Proteins; Neoplasm Proteins; Neuroendocrine Cells; ORAI1 Protein; Oxazoles; Phenotype; Prostatic Neoplasms; Stromal Interaction Molecule 1; TRPC Cation Channels | 2012 |
Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Benzenesulfonates; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Synergism; Fluorouracil; Humans; Isoenzymes; Male; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
Topics: Androgen Antagonists; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Drug; Fungicides, Industrial; Gene Expression; Humans; Immunoblotting; Insecticides; Luciferases; Male; Oxazoles; Prostatic Neoplasms; Pyrethrins; Receptors, Androgen; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation | 2006 |
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Topics: Alternative Splicing; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Down-Regulation; Emetine; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Marine Toxins; Okadaic Acid; Oxazoles; Prostatic Neoplasms; Protein Phosphatase 1; Protein Phosphatase 2; Up-Regulation; Uterine Cervical Neoplasms | 2007 |
Role of protein phosphorylation in TNF-induced apoptosis: phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants.
Topics: Alkaloids; Apoptosis; Breast Neoplasms; Carbazoles; DNA; Drug Synergism; Ethers, Cyclic; Humans; Indoles; Lymphoma, Large B-Cell, Diffuse; Male; Marine Toxins; Okadaic Acid; Oxazoles; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Prostatic Neoplasms; Protein Kinase Inhibitors; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
The role of a new liquid-solid scintillator, a mixture of DPO, POPOP and Epon 812, for enhancement of autoradiograms with tritium agents.
Topics: Animals; Antineoplastic Agents; Autoradiography; Epoxy Resins; Humans; Indicators and Reagents; Male; Mice; Mice, Nude; Oxazoles; Prostatic Neoplasms; Radionuclide Imaging; Scintillation Counting; Suramin; Transplantation, Heterologous; Tritium | 1998 |